journal article

P-42: Risk of neoplasm with fezolinetant: an analysis of the FDA Clinical Reviews

Authors
Publication date
10 September 2024
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Repository of the University of Namur

    redirect
    oaioai:pure.unamur.be:publication...
    Last time updated on 24/04/2025